PpThe Director Non‑Clinical Due Diligence External Evaluations provides scientific leadership for nonclinical due diligence supporting CSL’s in‑licensing, acquisitions, and strategic collaborations. The role ensures integrated, objective, and decision‑relevant evaluations of nonclinical pharmacology, PK/QSP, and toxicology data to identify development risks, data gaps, and mitigation strategies and to inform portfolio decisions. The incumbent will further act as nonclinical representative for selected Research programs and support oversight of nonclinical strategies and programs across all Therapeutic Areas. The role reports to the Executive Director, Head of Nonclinical Development. /ph3Responsibilities and Accountabilities /h3ulliLead operational execution of nonclinical due diligence for assigned opportunities. /liliAct as hands‑on scientific integrator, translating expert input into clear risk narratives. /liliTrusted subject‑matter lead for nonclinical DD on individual deals. /liliLead end‑to‑end nonclinical due diligence for individual assets or transactions, from request through final governance readout. /liliIntegrate input from Toxicology, PK/QSP, Nonclinical Pharmacology, and external experts into a single, coherent scientific assessment. /liliIdentify FIH‑enabling gaps, translational risks, and regulatory limitations, with clear mitigation proposals. /liliPrepare high‑quality DD reports, executive summaries, and risk tables for governance review. /liliAct as NCD scientific interface to Business Development and Therapeutic Area teams at the project level. /liliContribute to maintenance and continuous improvement of nonclinical DD frameworks and templates. /liliMentor junior contributors and matrix team members as appropriate. /liliEscalate complex or high‑impact issues to Head of NCD, Chair of “NCD Review Committee”. /li /ulh3Qualifications /h3ulliAdvanced degree (Ph.D., D.V.M., or equivalent) in toxicology, pharmacology, or a related field. /liliToxicology training, board certification preferred. /lili10+ years of experience in nonclinical development with proven due diligence or external innovation experience, ideally across various geographies. /liliStrong understanding of FIH‑enabling nonclinical requirements, particularly for biologics and complex modalities. /liliAbility to communicate complex scientific risk clearly to non‑expert stakeholders. /liliExperience across multiple therapeutic areas and modalities is highly desirable. /li /ulh3Competencies /h3ulliProven ability to work effectively independently or in a team setting, and to meet set goals by managing own timelines. /liliExperience working in cross‑functional, multicultural and international teams. /liliExcellent communication and analytical skills. /liliExperience in analyzing and presenting research results to scientific and professional audiences. /liliStrong planning and organizational skills. /liliAbility to work successfully in a matrix organizational structure. /liliStrong negotiation skills and ability to identify and engage internal and external expertise as needed. /liliGood understanding of drug development process, strong knowledge of ICH/GLP. /liliFluent in English, oral and written. /li /ulh3Location and Presence /h3pThe role requires onsite presence 3 days per week. The role can be based in Zurich, Switzerland or Waltham, USA. /ph3Equal Opportunity Employer /h3pCSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit CSL Global Privacy Notice for Job Applicants and Candidates. /p /p #J-18808-Ljbffr